Vectura Group Rating Reiterated by N+1 Singer (VEC)
Vectura Group (LON:VEC)‘s stock had its “hold” rating reaffirmed by N+1 Singer in a research note issued on Monday, Stock Ratings Network reports. They currently have a GBX 93 ($1.49) price objective on the stock. N+1 Singer’s target price would suggest a potential downside of 19.65% from the company’s current price.
Other equities research analysts have also recently issued reports about the stock. Analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Vectura Group (LON:VEC) in a research note to investors on Friday. Separately, analysts at Investec reiterated a “buy” rating on shares of Vectura Group (LON:VEC) in a research note to investors on Thursday, September 5th. They now have a GBX 148 ($2.37) price target on the stock, up previously from GBX 111 ($1.78).
One equities research analyst has rated the stock with a hold rating and nine have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of GBX 129.63 ($2.08).
Shares of Vectura Group (LON:VEC) traded up 2.89% during mid-day trading on Monday, hitting GBX 115.75. The stock had a trading volume of 819,275 shares. Vectura Group has a 52 week low of GBX 76.00 and a 52 week high of GBX 120.755. The stock’s 50-day moving average is GBX 102.8 and its 200-day moving average is GBX 90.80. The company’s market cap is £387.9 million.
Vectura Group plc (LON:VEC) is a developer of therapies principally for the treatment of respiratory diseases.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.